ViBRANT, a surrogate nuclear reactor, simulates neutron behavior with light to support safe development of advanced ...
With our homes and lives swarming with AI-powered devices, assistants and chatbots, a backlash is brewing. Pitched as “analog lifestyles,” it’s different than a short-term digital detox. Instead, it’s ...
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results